DK1409034T3 - Topisk farmaceutisk formulering - Google Patents

Topisk farmaceutisk formulering

Info

Publication number
DK1409034T3
DK1409034T3 DK02747591T DK02747591T DK1409034T3 DK 1409034 T3 DK1409034 T3 DK 1409034T3 DK 02747591 T DK02747591 T DK 02747591T DK 02747591 T DK02747591 T DK 02747591T DK 1409034 T3 DK1409034 T3 DK 1409034T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulation
topical pharmaceutical
admixture
composition
active agent
Prior art date
Application number
DK02747591T
Other languages
English (en)
Inventor
Alvin Berlat
Original Assignee
Advanced Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Biotechnologies filed Critical Advanced Biotechnologies
Application granted granted Critical
Publication of DK1409034T3 publication Critical patent/DK1409034T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02747591T 2001-07-24 2002-07-23 Topisk farmaceutisk formulering DK1409034T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30754801P 2001-07-24 2001-07-24

Publications (1)

Publication Number Publication Date
DK1409034T3 true DK1409034T3 (da) 2006-10-30

Family

ID=23190223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02747591T DK1409034T3 (da) 2001-07-24 2002-07-23 Topisk farmaceutisk formulering

Country Status (21)

Country Link
US (1) US8263114B2 (da)
EP (1) EP1409034B1 (da)
JP (1) JP3778559B2 (da)
KR (1) KR101009267B1 (da)
CN (1) CN1234426C (da)
AT (1) ATE331537T1 (da)
AU (1) AU2002317981B2 (da)
BR (1) BRPI0211282B8 (da)
CA (1) CA2454673C (da)
DE (1) DE60212847T2 (da)
DK (1) DK1409034T3 (da)
ES (1) ES2268061T3 (da)
HK (1) HK1061362A1 (da)
IL (2) IL160109A0 (da)
MX (1) MXPA04000444A (da)
NO (1) NO334175B1 (da)
NZ (1) NZ529957A (da)
PT (1) PT1409034E (da)
RU (1) RU2306121C2 (da)
WO (1) WO2003009877A1 (da)
ZA (1) ZA200400488B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237834A1 (en) * 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
WO2005003032A1 (en) * 2003-07-03 2005-01-13 The University Court Of The University Of St Andrews Zeolites for delivery of nitric oxide
KR20140013078A (ko) * 2004-11-07 2014-02-04 쿠프론 인코포레이티드 상처, 화상 및 다른 피부 질환을 치료하기 위한 구리 함유 물질
CA2637447A1 (en) * 2006-01-30 2007-08-02 Sanjeev Kaila A composition including a silicone-based polymer and a method of treating skin disorders using the composition
CA2692187A1 (en) * 2007-06-29 2009-01-08 Carmanah Technologies Corp. Intelligent area lighting system
UA28103U (uk) 2007-07-12 2007-11-26 Ольга Олександрівна Біляєва Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en) 2008-11-21 2008-12-31 P Q Silicas Uk Ltd Composition and dressing with nitric oxide
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
US20100322875A1 (en) * 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
WO2011009083A1 (en) * 2009-07-17 2011-01-20 Carefusion 2200, Inc. Particles incorporating antimicrobial agents
RU2429820C2 (ru) * 2009-09-24 2011-09-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН") Антисептическая мазь наружного применения (2 варианта)
CN102665765A (zh) * 2009-11-03 2012-09-12 立普妥公司 促进创伤愈合的组合物
SI2496263T1 (sl) * 2009-11-03 2022-05-31 Lipidor Ab Sestavek, ki tvori lipidni sloj, za dajanje na površino živega organizma
ES2831299T3 (es) * 2010-06-17 2021-06-08 Covalon Tech Inc Apósito para heridas a base de silicona antimicrobiano
WO2012150890A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Antibacterial composition
US20130144225A1 (en) 2011-12-06 2013-06-06 Jessica Rowen Method And Device For Scar Management
TWI474823B (zh) * 2013-09-25 2015-03-01 Far Eastern New Century Corp 疤痕凝膠的組成物
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) * 2016-12-22 2017-05-31 苏州迈达医疗器械有限公司 一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en) 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) * 2017-12-11 2018-12-10 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Спрей для наружного применения спиртовой
CN108714141A (zh) * 2018-05-29 2018-10-30 南京华开生物科技有限公司 硅酮疤痕喷剂
US12084550B2 (en) 2018-07-26 2024-09-10 Exciton Pharma Corp. Vehicles and delivery systems for oxidizing agents
WO2020061671A1 (en) * 2018-09-26 2020-04-02 Exaltexx Inc. Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en) 2019-03-28 2022-09-06 L'oreal Cosmetic compositions for skin
US11364190B2 (en) 2019-07-30 2022-06-21 L'oreal Acid perfluoro-free self-foaming facial cleanser composition
US11207255B2 (en) 2019-07-30 2021-12-28 L'oreal Perfluoro-free self-foaming facial cleanser composition
US12109279B2 (en) 2020-08-25 2024-10-08 L'oreal Self-bubbling peel-away cleansing mask
US11213473B1 (en) 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618899B2 (ja) * 1987-06-30 1994-03-16 品川燃料株式会社 抗菌性ゼオライト含有フィルム
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
JPH049327A (ja) 1990-04-04 1992-01-14 Kootec Kk 創傷被覆材
FR2678513B1 (fr) * 1991-07-03 1995-06-30 Laboratoires Hygiene Dietetique Pansement cicatrisant.
EP0848621B1 (en) 1995-07-19 2003-03-26 Advanced Medical Solutions Limited Wound treatment composition
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja) 1996-01-19 1997-07-29 Morishita Jintan Kk 創傷被覆材
US6231259B1 (en) * 1996-07-26 2001-05-15 The Gillette Company Viscous product dispenser with porous dome
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
WO1999030629A1 (en) * 1997-12-17 1999-06-24 Hemodynamics, Inc. Sealing media for surgery and wound closure
WO2000047183A1 (en) 1999-02-12 2000-08-17 The Procter & Gamble Company Skin sanitizing compositions
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
GB0007140D0 (en) * 1999-09-27 2000-05-17 Dow Corning Sa Scar treatment composition
AU2001256347A1 (en) * 2000-05-23 2001-12-03 Unilever Plc Deodorant and/or antiperspirant compositions
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
SI2211919T1 (sl) * 2007-09-30 2012-02-29 Meda Ab Sestavki na osnovi silikonskega gela za celjenje ran in zmanjšanje brazgotin

Also Published As

Publication number Publication date
EP1409034A1 (en) 2004-04-21
CN1527729A (zh) 2004-09-08
MXPA04000444A (es) 2004-10-27
BR0211282B1 (pt) 2018-01-09
DE60212847D1 (de) 2006-08-10
CA2454673C (en) 2011-04-26
EP1409034B1 (en) 2006-06-28
CA2454673A1 (en) 2003-02-06
JP2005502639A (ja) 2005-01-27
RU2004105164A (ru) 2005-06-27
NO334175B1 (no) 2014-01-06
PT1409034E (pt) 2006-11-30
BRPI0211282B8 (pt) 2021-05-25
BR0211282A (pt) 2004-08-03
KR20040032864A (ko) 2004-04-17
ES2268061T3 (es) 2007-03-16
AU2002317981B2 (en) 2006-12-07
ZA200400488B (en) 2005-06-29
NZ529957A (en) 2005-11-25
WO2003009877A1 (en) 2003-02-06
ATE331537T1 (de) 2006-07-15
CN1234426C (zh) 2006-01-04
JP3778559B2 (ja) 2006-05-24
IL160109A0 (en) 2004-06-20
HK1061362A1 (en) 2004-09-17
US8263114B2 (en) 2012-09-11
IL160109A (en) 2008-04-13
US20040234474A1 (en) 2004-11-25
KR101009267B1 (ko) 2011-01-18
NO20040319L (no) 2004-01-23
RU2306121C2 (ru) 2007-09-20
DE60212847T2 (de) 2007-06-14

Similar Documents

Publication Publication Date Title
DK1409034T3 (da) Topisk farmaceutisk formulering
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ID27504A (id) Formulasi oral baru
EE05210B1 (et) Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
NO20024099L (no) Lavdose entecavir-formulering og anvendelse
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
DE60104255D1 (de) Misch- und Zufuhrport für medizinische Anwendungen
HK1076755A1 (en) Wound dressing
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
NO20040254L (no) Farmasoytiske sammensetninger som inneholder terbinafin og anvendelse derav
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
ATE314084T1 (de) Kahalalid f formulierung
NO20040702L (no) Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
BR0213278B1 (pt) composição vedante e seu uso.
AR030853A1 (es) Composicion plaguicida
SE0103276D0 (sv) Anordning för administrering av salva till en hudyta
HK1063469A1 (en) N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans
PT1305314E (pt) Agente terapeutico cristalino
DE60139348D1 (de) Photohärtbare zusammensetzung sowie photoreaktive klebstoff-zusammensetzungen
FR2827764B1 (fr) Composition, notamment cosmetique, renfermant un steroide et un glycol
IT1318654B1 (it) Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.
DE60234604D1 (de) Orale dosierungsform enthaltend einen therapeutischen wirkstoff und einen gegenwirdenden wirkstoff
AU2001295301A1 (en) Medicinal composition and in particular its use in fluid therapy
CR6300A (es) Nueva formulacion oral